Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa C Lindesmith

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Mbio|September 14, 2022
Immune Imprinting Drives Human Norovirus Potential for Global SpreadLisa C Lindesmith, Florencia A T Boshier, Paul D Brewer-Jensen, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus MacaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Science Immunology|June 16, 2021
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Science Translational Medicine|March 5, 2025
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirusJuyeon Park, Lisa C Lindesmith, Adam S Olia, et al.
Science Advances|March 27, 2026
One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine developmentNathan A Ona, Dapeng Zhang, Lisa C Lindesmith, et al.
Annals of the New York Academy of Sciences|April 6, 2023
Progress in vaccine development for infectious diseases-a Keystone Symposia reportJennifer Cable, Barney S Graham, Richard A Koup, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Mbio|September 14, 2022
Immune Imprinting Drives Human Norovirus Potential for Global SpreadLisa C Lindesmith, Florencia A T Boshier, Paul D Brewer-Jensen, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus MacaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Science Immunology|June 16, 2021
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Science Translational Medicine|March 5, 2025
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirusJuyeon Park, Lisa C Lindesmith, Adam S Olia, et al.
Science Advances|March 27, 2026
One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine developmentNathan A Ona, Dapeng Zhang, Lisa C Lindesmith, et al.
Annals of the New York Academy of Sciences|April 6, 2023
Progress in vaccine development for infectious diseases-a Keystone Symposia reportJennifer Cable, Barney S Graham, Richard A Koup, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 7